Device Craniomaxillofacial

Vsp System, Vsp Cranial

Payments companies reported to CMS as associated with Vsp System, Vsp Cranial. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.3Massociated payments (2023-2025)
1,715clinicians with associated payments
1company reporting

By year

2023 $519K
2024 $298K
2025 $487K

Payments reported as associated with Vsp System, Vsp Cranial, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Oral and Maxillofacial Surgery $491K
Otolaryngology $245K
Oral & Maxillofacial Surgery $237K
Ophthalmic Plastic and Reconstructive Surgery $71K
Plastic Surgery $68K
Facial Plastic Surgery $31K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vsp System, Vsp Cranial

These are the largest totals companies reported as associated with Vsp System, Vsp Cranial. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mark Ochs Pittsburgh, PA Oral and Maxillofacial Surgery $162,185.66
Alan Herford Colton, CA Oral and Maxillofacial Surgery $109,410.21
Shahid Aziz Newark, NJ Oral & Maxillofacial Surgery $89,344.56
Andrew Winkler Aurora, CO Otolaryngology $82,466.97
Keith Blackwell Los Angeles, CA Otolaryngology $74,991.40
Vikram Durairaj Austin, TX Ophthalmic Plastic and Reconstructive Surgery $71,216.20
Sean Edwards Ann Arbor, MI Oral and Maxillofacial Surgery $68,853.18
Craig Birgfeld Seattle, WA Plastic Surgery $56,880.65
Donita Dyalram Baltimore, MD Oral & Maxillofacial Surgery $55,098.09
Oluwafunmilola Okuyemi Las Vegas, NV Otolaryngology $53,669.01

Prescribed Vsp System, Vsp Cranial?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.